-
EP2812006
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2812006
| EP2812006 - INJECTABLE COMPOSITION CONTAINING PHOSPHATIDYLCHOLINE DEVOID OF SODIUM DEOXYCHOLATE AND PREPARING METHOD THEREOF [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 12.06.2015 Database last updated on 20.05.2024 | Most recent event Tooltip | 12.06.2015 | Withdrawal of application | published on 15.07.2015 [2015/29] | Applicant(s) | For all designated states AMI Pharm Co., Ltd. (Dogok dong, How Building) 6th Floor, 148 Dogok-ro Gangnam-gu Seoul 135-271 / KR | [2014/51] | Inventor(s) | 01 /
LEE, Ki Teak 6-3306 Parkview Jeongja-dong Bundang-gu Seongnam-si Gyeonggi-do 463-811 / KR | 02 /
LEE, Jong Hyuk 202 Woorihome Town 275 Yeonhui-dong Seodaemun-gu Seoul 120-831 / KR | 03 /
SEONG, Ilkyeong 337-13 Uam-dong Sangdang-gu Cheongju-si Chuncheongbuk-do 360-814 / KR | [2014/51] | Representative(s) | Stolmár & Partner Patentanwälte PartG mbB Blumenstrasse 17 80331 München / DE | [N/P] |
| Former [2014/51] | Stolmár & Partner Blumenstrasse 17 80331 München / DE | Application number, filing date | 13746535.7 | 07.02.2013 | WO2013KR00999 | Priority number, date | KR20120012360 | 07.02.2012 Original published format: KR 20120012360 | [2014/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013119059 | Date: | 15.08.2013 | Language: | EN | [2013/33] | Type: | A1 Application with search report | No.: | EP2812006 | Date: | 17.12.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.08.2013 takes the place of the publication of the European patent application. | [2014/51] | Search report(s) | International search report - published on: | KR | 15.08.2013 | (Supplementary) European search report - dispatched on: | EP | 05.06.2015 | Classification | IPC: | A61K9/107, A61K47/24, A61K47/26, A61K9/08, A61K47/10, A61K31/685 | [2015/28] | CPC: |
A61K9/0019 (EP,US);
A61K31/661 (KR);
A61K9/08 (KR,US);
A61K31/66 (KR);
A61K31/675 (KR);
A61K31/685 (EP,US);
A61K47/10 (EP,US);
A61K47/24 (EP,US);
A61K47/26 (EP,US);
|
| Former IPC [2014/51] | A61K31/661, A61K31/66, A61K31/675, A61K9/08 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/51] | Title | German: | INJIZIERBARE ZUSAMMENSETZUNG MIT PHOSPHATIDYLCHOLIN OHNE NATRIUMDEOXYCHOLAT UND HERSTELLUNGSVERFAHREN DAFÜR | [2014/51] | English: | INJECTABLE COMPOSITION CONTAINING PHOSPHATIDYLCHOLINE DEVOID OF SODIUM DEOXYCHOLATE AND PREPARING METHOD THEREOF | [2014/51] | French: | COMPOSITION INJECTABLE CONTENANT DE LA PHOSPHATIDYLCHOLINE EXEMPTE DE DÉSOXYCHOLATE DE SODIUM ET PROCÉDÉ DE PRÉPARATION DE CELLE-CI | [2014/51] | Entry into regional phase | 08.07.2014 | National basic fee paid | 08.07.2014 | Search fee paid | 08.07.2014 | Designation fee(s) paid | 08.07.2014 | Examination fee paid | Examination procedure | 08.07.2014 | Examination requested [2014/51] | 03.06.2015 | Application withdrawn by applicant [2015/29] | Fees paid | Renewal fee | 27.02.2015 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]US2005267080 (KOLODNEY MICHAEL S [US], et al) [Y] 1-4* example - *; | [Y]WO2011022707 (KROON HENK-ANDRE [US], et al) [Y] 1-4 * paragraphs [0010] , [0026]; example - * | International search | [A]KR20040108567 (DOOSAN CORP); | [A]JP2007509085 (AVENTIS PHARMA DEUTSCHLAND GMBH ET AL.); | [A]KR20070110351 (LOS ANGELES BIOMED RES INST [US], et al); | [A]WO2011024354 (MEDRX CO LTD [JP], et al) |